ALXN1820

· Alexion Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ALXN1820, covering 2024-03-15 to 2025-01-13. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Efficacy, Pharmacokinetic, and Pharmacodynamic Study of ALXN1820 in Adult Participants With Sickle Cell Disease [Phase 2]

See pricing